Evaluation of the factor Xa inhibitor, PRT054021, against enoxaparin in a randomized trial for the prevention of venous thromboembolic events after unilateral total knee replacement (EXPERT),

Trial Profile

Evaluation of the factor Xa inhibitor, PRT054021, against enoxaparin in a randomized trial for the prevention of venous thromboembolic events after unilateral total knee replacement (EXPERT),

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Betrixaban; Enoxaparin sodium
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Acronyms EXPERT
  • Most Recent Events

    • 10 Sep 2007 Status changed from recruiting to completed.
    • 06 Jul 2007 Results have been presented.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top